Both external and internal advisory committees have been established in order to optimize the SKCCC's success and to provide comprehensive, expert direction for our research activities. The Director seeks external advice to guide the development and direction of the SKCCC from a variety of sources, including the leadership of the University and Hospital, ad hoc consultants, and an External Advisory Board. Several internal advisory committees assist the Cancer Center in strategic and program planning, resource allocation, and identifying new initiatives and opportunities. The governance of the SKCCC is aimed at two major objectives: 1) maximizing the use of Cancer Center resources (human and physical) to achieve research goals;and 2) creating an efficient, effective, responsive and collegial enterprise. These committee include: 1) Executive Committee;2) Research Council;3) Protocol Review and Monitoring Committee 4) Safety Monitoring Committee;5) Laboratory Shared Resources Committee and 6) Clinical Research Operations Committee. The External Advisory Board (EAB) is composed of national leaders representing major areas of cancer research from preeminent institutions other than Johns Hopkins. This Advisory Board has played a critical role in the evaluation of scientific programs as well as assessment of the programmatic structure of this Cancer Center. Members of this Advisory Board have also been generous of their time in providing individual consultations in specific areas of their expertise.
| Nauman, Gina; Gray, Javaughn Corey; Parkinson, Rose et al. (2018) Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials. Antioxidants (Basel) 7: |
| Ransome, Yusuf; Thurber, Katherine A; Swen, Melody et al. (2018) Social capital and HIV/AIDS in the United States: Knowledge, gaps, and future directions. SSM Popul Health 5:73-85 |
| Qiu, Xiang; Kumari, Gita; Gerasimova, Tatiana et al. (2018) Sequential Enhancer Sequestration Dysregulates Recombination Center Formation at the IgH Locus. Mol Cell 70:21-33.e6 |
| Haffner, Michael C; Taheri, Diana; Luidy-Imada, Eddie et al. (2018) Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors. Proc Natl Acad Sci U S A 115:E8580-E8582 |
| Bastos, Diogo A; Antonarakis, Emmanuel S (2018) CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer. Expert Rev Mol Diagn 18:155-163 |
| Afsari, Bahman; Guo, Theresa; Considine, Michael et al. (2018) Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer. Bioinformatics 34:1859-1867 |
| Kagohara, Luciane T; Stein-O'Brien, Genevieve L; Kelley, Dylan et al. (2018) Epigenetic regulation of gene expression in cancer: techniques, resources and analysis. Brief Funct Genomics 17:49-63 |
| De Silva, Ravindra A; Kumar, Dhiraj; Lisok, Ala et al. (2018) Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer. Mol Pharm 15:3946-3952 |
| Martin, Allison M; Nirschl, Christopher J; Polanczyk, Magda J et al. (2018) PD-L1 expression in medulloblastoma: an evaluation by subgroup. Oncotarget 9:19177-19191 |
| Yeruva, Sri Lakshmi Hyndavi; Javadi, Mehrbod Som; Stearns, Vered (2018) Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report. Clin Breast Cancer 18:e277-e280 |
Showing the most recent 10 out of 2393 publications
